CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 253 filers reported holding CUBIST PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $25,716,000 | +6187.5% | 255,500 | +4254.1% | 0.15% | +4933.3% |
| Q2 2014 | $409,000 | -96.2% | 5,868 | -96.2% | 0.00% | -95.6% |
| Q4 2013 | $10,699,000 | +34.5% | 155,355 | +24.2% | 0.07% | -12.8% |
| Q3 2013 | $7,952,000 | +34.4% | 125,120 | +2.1% | 0.08% | +21.9% |
| Q2 2013 | $5,916,000 | – | 122,495 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 756,821 | $36,547,000 | 4.31% |
| SECTOR GAMMA AS | 289,442 | $13,977,000 | 4.08% |
| HealthCor Management, L.P. | 1,200,000 | $57,948,000 | 3.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,500,000 | $72,435,000 | 3.41% |
| Duquesne Family Office | 413,000 | $19,944,000 | 2.96% |
| KING INVESTMENT ADVISORS INC/TX | 127,705 | $6,167,000 | 2.56% |
| BNP PARIBAS FINANCIAL MARKETS | 17,275,000 | $3,026,410,000,000 | 2.14% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 572,762 | $27,658,000 | 1.84% |
| Tekla Capital Management LLC | 265,972 | $12,846,000 | 1.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 695,000 | $33,562,000 | 1.58% |